Find a service?

Contact Request

NCT07210515

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

Registry fields

Overall status: RECRUITING
Conditions: Complex Regional Pain Syndrome Type I
Study type: INTERVENTIONAL
Phase: PHASE3
Primary purpose: TREATMENT
Intervention type: DRUG
Interventions: Neridronate, Placebo
Lead sponsor: Ambros Therapeutics, Inc. (INDUSTRY)

Cached at: 2026-08-14 23:49:39

View on ClinicalTrials.gov

Brief summary

Phase 3 Trial of AMBTX-01 (neridronate) for Complex Regional Pain Syndrome Type 1

Contact

Need a report or Korean medical writing based on this trial?

Request a report Medical writing Custom research report